|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | KEGG: Kyoto Encyclopedia of Genes and Genomes | KEGG |
3. | 3-Thia fatty acid treatment, in contrast to eicosapentaenoic acid and starvation, induces gene expression of carnitine palmitoyltransferase-II in rat liver. | Madsen L and Berge RK, Lipids. 1999 May;34(5):447-56. doi: 10.1007/s11745-999-0384-6. |
4. | Mitochondrial 3-hydroxy-3-methylglutaryl coenzyme A synthase and carnitine palmitoyltransferase II as potential control sites for ketogenesis during mitochondrion and peroxisome proliferation. | Madsen L, etal., Biochem Pharmacol. 1999 May 1;57(9):1011-9. |
5. | OMIM Disease Annotation Pipeline | OMIM Disease Annotation Pipeline |
6. | SMPDB Annotation Import Pipeline | Pipeline to import SMPDB annotations from SMPDB into RGD |
7. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
8. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
9. | RGD HPO Phenotype Annotation Pipeline | RGD automated import pipeline for human HPO-to-gene-to-disease annotations |
10. | Structural insight into function and regulation of carnitine palmitoyltransferase. | Rufer AC, etal., Cell Mol Life Sci. 2009 Aug;66(15):2489-501. Epub 2009 May 9. |
11. | Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. | Taroni F, etal., Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8429-33. |
12. | A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene. | Vladutiu GD, etal., Mol Genet Metab 2000 Jun;70(2):134-41. |
13. | Effect of Creosote Bush-Derived NDGA on Expression of Genes Involved in Lipid Metabolism in Liver of High-Fructose Fed Rats: Relevance to NDGA Amelioration of Hypertriglyceridemia and Hepatic Steatosis. | Zhang H, etal., PLoS One. 2015 Sep 22;10(9):e0138203. doi: 10.1371/journal.pone.0138203. eCollection 2015. |
PMID:1961767 | PMID:1988962 | PMID:2174799 | PMID:7711730 | PMID:7892212 | PMID:7896283 | PMID:8086471 | PMID:8125298 | PMID:8358442 | PMID:8499929 | PMID:8651281 | PMID:9600456 |
PMID:9758712 | PMID:10090476 | PMID:10607472 | PMID:11001805 | PMID:11095714 | PMID:11257506 | PMID:11477613 | PMID:11855939 | PMID:11994355 | PMID:12408750 | PMID:12410208 | PMID:12477932 |
PMID:12707442 | PMID:12971426 | PMID:14605500 | PMID:14615409 | PMID:15489334 | PMID:15622536 | PMID:15642848 | PMID:15647998 | PMID:15754283 | PMID:16054041 | PMID:16168441 | PMID:16670153 |
PMID:16671104 | PMID:16710414 | PMID:16996287 | PMID:17179390 | PMID:17651973 | PMID:17709715 | PMID:17936304 | PMID:18024217 | PMID:18029348 | PMID:18306170 | PMID:18363739 | PMID:18550408 |
PMID:18645163 | PMID:18996102 | PMID:19362304 | PMID:19762733 | PMID:19913121 | PMID:20186120 | PMID:20301431 | PMID:20370797 | PMID:20538056 | PMID:20602615 | PMID:20628086 | PMID:20810031 |
PMID:20877624 | PMID:20934285 | PMID:20952238 | PMID:21277129 | PMID:21641254 | PMID:21697855 | PMID:21873635 | PMID:21913903 | PMID:22199357 | PMID:22493507 | PMID:23322164 | PMID:23475205 |
PMID:23566841 | PMID:23969168 | PMID:24398345 | PMID:24816252 | PMID:25335471 | PMID:25361188 | PMID:25578732 | PMID:25781464 | PMID:26041663 | PMID:26186194 | PMID:26344197 | PMID:26874509 |
PMID:27034144 | PMID:27499296 | PMID:27502741 | PMID:27525900 | PMID:28054946 | PMID:28380382 | PMID:28514442 | PMID:30007356 | PMID:30097533 | PMID:30604089 | PMID:31151054 | PMID:31201655 |
PMID:31280863 | PMID:31351739 | PMID:31536960 | PMID:31599017 | PMID:31932471 | PMID:32296183 | PMID:32628020 | PMID:32848104 | PMID:32877691 | PMID:33207079 | PMID:33961781 | PMID:34020866 |
PMID:34626609 | PMID:34709727 | PMID:34800366 | PMID:35013556 | PMID:35108639 | PMID:35384245 | PMID:35446349 | PMID:35545034 | PMID:35831314 | PMID:36195841 | PMID:36215168 | PMID:37827155 |
PMID:37926998 | PMID:37950149 | PMID:38395422 | PMID:38428407 |
CPT2 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cpt2 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cpt2 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cpt2 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CPT2 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CPT2 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cpt2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CPT2 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CPT2 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cpt2 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in CPT2
848 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_000098.3(CPT2):c.1858T>C (p.Trp620Arg) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451151]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451152]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003451150]|Carnitine palmitoyltransferase II deficiency [RCV000530360]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003451153]|Inborn genetic diseases [RCV002527740] | Chr1:53213476 [GRCh38] Chr1:53679148 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.833C>T (p.Ser278Leu) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451165]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451166]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002497101]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003451164]|Carnitine palmitoyltransferase II deficiency [RCV000525082]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456090] | Chr1:53210507 [GRCh38] Chr1:53676179 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.984T>A (p.Asp328Glu) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV002535029]|not provided [RCV000722289] | Chr1:53210658 [GRCh38] Chr1:53676330 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.960G>A (p.Ser320=) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV001500528] | Chr1:53210634 [GRCh38] Chr1:53676306 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000415574]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009508]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002476950]|Carnitine palmitoyltransferase II deficiency [RCV000202472]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473062]|not provided [RCV001781211] | Chr1:53213509 [GRCh38] Chr1:53679181 [GRCh37] Chr1:1p32.3 |
pathogenic |
NM_000098.3(CPT2):c.338C>T (p.Ser113Leu) | single nucleotide variant | Abnormality of the musculature [RCV001813968]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009510]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000194764]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000515252]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000576571]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004157]|Carnitine palmitoyltransferase II deficiency [RCV000202499]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003137507]|Inborn genetic diseases [RCV000624845]|Rhabdomyolysis [RCV000662284]|not provided [RCV000185836] | Chr1:53202427 [GRCh38] Chr1:53668099 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.149C>A (p.Pro50His) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009511]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009512]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762941]|Carnitine palmitoyltransferase II deficiency [RCV000202440]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473063]|Pancytopenia [RCV000735345]|not provided [RCV000440440] | Chr1:53197092 [GRCh38] Chr1:53662764 [GRCh37] Chr1:1p32.3 |
pathogenic |
NM_000098.3(CPT2):c.1657G>A (p.Asp553Asn) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009513]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000675130] | Chr1:53213275 [GRCh38] Chr1:53678947 [GRCh37] Chr1:1p32.3 |
pathogenic|uncertain significance |
NM_000098.3(CPT2):c.1883A>C (p.Tyr628Ser) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000415611]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009514]|Carnitine palmitoyltransferase II deficiency [RCV000202449] | Chr1:53213501 [GRCh38] Chr1:53679173 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|not provided |
NM_000098.3(CPT2):c.520G>A (p.Glu174Lys) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009516]|Carnitine palmitoyltransferase II deficiency [RCV000202437]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473064] | Chr1:53210194 [GRCh38] Chr1:53675866 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009518]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000411002]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009517]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762943]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004159]|Carnitine palmitoyltransferase II deficiency [RCV000202462]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473065]|Seizure [RCV001270097] | Chr1:53210822 [GRCh38] Chr1:53676494 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009519]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004160]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002490348]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003450624]|Carnitine palmitoyltransferase II deficiency [RCV000202513]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473066]|not provided [RCV003317032] | Chr1:53211181 [GRCh38] Chr1:53676853 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
CPT2, 1-BP INS/25-BP DEL, NT534 | indel | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009523] | Chr1:1p32 | pathogenic |
NM_000098.3(CPT2):c.234-1G>A | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009524] | Chr1:53202322 [GRCh38] Chr1:53667994 [GRCh37] Chr1:1p32.3 |
pathogenic |
CPT2, 11-BP DUP, NT997 | duplication | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009525] | Chr1:1p32 | pathogenic |
NM_000098.3(CPT2):c.680C>T (p.Pro227Leu) | single nucleotide variant | CPT2-related disorder [RCV003934818]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009526]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000576348]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002496314]|Carnitine palmitoyltransferase II deficiency [RCV000202466]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473067]|not provided [RCV000185840] | Chr1:53210354 [GRCh38] Chr1:53676026 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|uncertain significance |
CPT2, 3-BP DEL/5-BP INS, NT109 | indel | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000009527] | Chr1:1p32 | pathogenic |
NM_000098.3(CPT2):c.1360G>T (p.Glu454Ter) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009528]|Carnitine palmitoyltransferase II deficiency [RCV001851765] | Chr1:53211034 [GRCh38] Chr1:53676706 [GRCh37] Chr1:1p32.3 |
pathogenic |
NM_000098.3(CPT2):c.638A>G (p.Asp213Gly) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000009529]|Carnitine palmitoyltransferase II deficiency [RCV003581557] | Chr1:53210312 [GRCh38] Chr1:53675984 [GRCh37] Chr1:1p32.3 |
pathogenic |
NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000409888]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000408956]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000009530]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762942]|Carnitine palmitoyltransferase II deficiency [RCV000202546]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003473068]|not provided [RCV001781212] | Chr1:53210033 [GRCh38] Chr1:53675705 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.1080C>T (p.Ile360=) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451701]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451702]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002488215]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003451700]|Carnitine palmitoyltransferase II deficiency [RCV001394458]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003451703] | Chr1:53210754 [GRCh38] Chr1:53676426 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.3(CPT2):c.1654T>C (p.Phe552Leu) | single nucleotide variant | not provided [RCV000722790] | Chr1:53213272 [GRCh38] Chr1:53678944 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.365C>T (p.Ser122Phe) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000536664]|not provided [RCV001532537]|not specified [RCV000518089] | Chr1:53210039 [GRCh38] Chr1:53675711 [GRCh37] Chr1:1p32.3 |
likely benign|uncertain significance |
NM_000098.3(CPT2):c.1675C>G (p.Leu559Val) | single nucleotide variant | not provided [RCV000722483] | Chr1:53213293 [GRCh38] Chr1:53678965 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1941G>A (p.Met647Ile) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000545256] | Chr1:53213559 [GRCh38] Chr1:53679231 [GRCh37] Chr1:1p32.3 |
likely benign|uncertain significance |
NM_000098.3(CPT2):c.1718T>G (p.Leu573Arg) | single nucleotide variant | not provided [RCV000723110] | Chr1:53213336 [GRCh38] Chr1:53679008 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1679G>A (p.Arg560Gln) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449550]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449551]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000672447]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000763963]|Carnitine palmitoyltransferase II deficiency [RCV000527595]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456088]|not provided [RCV003144325] | Chr1:53213297 [GRCh38] Chr1:53678969 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1806T>C (p.Phe602=) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001449948]|Carnitine palmitoyltransferase II deficiency [RCV001082115]|not provided [RCV000596578]|not specified [RCV001264437] | Chr1:53213424 [GRCh38] Chr1:53679096 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NC_000001.11:g.(?_53200699)_(53200819_?)del | deletion | Carnitine palmitoyltransferase II deficiency [RCV000544302] | Chr1:53200699..53200819 [GRCh38] Chr1:53666371..53666491 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.932A>G (p.Asn311Ser) | single nucleotide variant | CPT2-related disorder [RCV003962430]|Carnitine palmitoyltransferase II deficiency [RCV000549753]|not specified [RCV000517266] | Chr1:53210606 [GRCh38] Chr1:53676278 [GRCh37] Chr1:1p32.3 |
likely benign|uncertain significance |
NM_000098.3(CPT2):c.1372A>C (p.Lys458Gln) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001334222]|Carnitine palmitoyltransferase II deficiency [RCV001085292]|not provided [RCV000521689] | Chr1:53211046 [GRCh38] Chr1:53676718 [GRCh37] Chr1:1p32.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh38/hg38 1p32.3-31.3(chr1:50222546-61618373)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051819]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051819]|See cases [RCV000051819] | Chr1:50222546..61618373 [GRCh38] Chr1:50688218..62084045 [GRCh37] Chr1:50460805..61856633 [NCBI36] Chr1:1p32.3-31.3 |
pathogenic |
GRCh38/hg38 1p32.3-31.1(chr1:52595352-76767765)x3 | copy number gain | See cases [RCV000051822] | Chr1:52595352..76767765 [GRCh38] Chr1:53061024..77233450 [GRCh37] Chr1:52833612..77006038 [NCBI36] Chr1:1p32.3-31.1 |
pathogenic |
NM_000098.2(CPT2):c.1680G>A (p.Arg560=) | single nucleotide variant | Malignant melanoma [RCV000064817] | Chr1:53213298 [GRCh38] Chr1:53678970 [GRCh37] Chr1:53451558 [NCBI36] Chr1:1p32.3 |
not provided |
NM_000098.3(CPT2):c.1055T>G (p.Phe352Cys) | single nucleotide variant | CPT2-related disorder [RCV003982874]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453000]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453001]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000578014]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003452999]|Carnitine palmitoyltransferase II deficiency [RCV000202443]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456002]|not provided [RCV000444353]|not specified [RCV000078115] | Chr1:53210729 [GRCh38] Chr1:53210729..53210730 [GRCh38] Chr1:53676401 [GRCh37] Chr1:53676401..53676402 [GRCh37] Chr1:1p32.3 |
likely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.1102G>A (p.Val368Ile) | single nucleotide variant | CPT2-related disorder [RCV003974955]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001533572]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001533571]|Carnitine palmitoyltransferase II deficiency [RCV000202483]|not provided [RCV000711317]|not specified [RCV000078116] | Chr1:53210776 [GRCh38] Chr1:53676448 [GRCh37] Chr1:1p32.3 |
benign |
NM_000098.3(CPT2):c.1239_1240del (p.Lys414fs) | deletion | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV002225079]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000576522]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002490673]|Carnitine palmitoyltransferase II deficiency [RCV000202516]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474675]|not provided [RCV000185837] | Chr1:53210912..53210913 [GRCh38] Chr1:53676584..53676585 [GRCh37] Chr1:1p32.3 |
pathogenic |
NM_000098.3(CPT2):c.1547T>C (p.Phe516Ser) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV001854372]|not provided [RCV000078118] | Chr1:53211221 [GRCh38] Chr1:53676893 [GRCh37] Chr1:1p32.3 |
likely pathogenic|uncertain significance |
NM_000098.3(CPT2):c.1767G>A (p.Thr589=) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453003]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453004]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002498374]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003453002]|Carnitine palmitoyltransferase II deficiency [RCV000553368]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456003]|not provided [RCV003656100]|not specified [RCV000078119] | Chr1:53213385 [GRCh38] Chr1:53679057 [GRCh37] Chr1:1p32.3 |
benign|likely benign |
NM_000098.3(CPT2):c.1939A>G (p.Met647Val) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001533573]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000578093]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000986323]|Carnitine palmitoyltransferase II deficiency [RCV000202533]|not provided [RCV001811357]|not specified [RCV000078120] | Chr1:53213557 [GRCh38] Chr1:53213557..53213558 [GRCh38] Chr1:53679229 [GRCh37] Chr1:53679229..53679230 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.341-16T>C | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV002055091]|not provided [RCV000078122] | Chr1:53209999 [GRCh38] Chr1:53675671 [GRCh37] Chr1:1p32.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.302C>T (p.Ala101Val) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453055]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453056]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000986322]|Carnitine palmitoyltransferase II deficiency [RCV000544913]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456004]|not provided [RCV001704048]|not specified [RCV000124603] | Chr1:53202391 [GRCh38] Chr1:53668063 [GRCh37] Chr1:1p32.3 |
benign |
NM_000098.3(CPT2):c.534_558delinsT (p.Leu178_Ile186delinsPhe) | indel | CPT2-related disorder [RCV003398720]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV002274921]|Carnitine palmitoyltransferase II deficiency [RCV000202494]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474723]|not provided [RCV000414700] | Chr1:53210208..53210232 [GRCh38] Chr1:53675880..53675904 [GRCh37] Chr1:1p32.3 |
pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.511C>T (p.Leu171=) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454456]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454457]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454455]|Carnitine palmitoyltransferase II deficiency [RCV000385074]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003454458]|not provided [RCV001706139]|not specified [RCV000178037] | Chr1:53210185 [GRCh38] Chr1:53675857 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.143G>A (p.Ser48Asn) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV001348111] | Chr1:53197086 [GRCh38] Chr1:53662758 [GRCh37] Chr1:1p32.3 |
uncertain significance |
GRCh38/hg38 1p32.3-31.3(chr1:52787503-67339873)x3 | copy number gain | See cases [RCV000141758] | Chr1:52787503..67339873 [GRCh38] Chr1:53253175..67805556 [GRCh37] Chr1:53025763..67578144 [NCBI36] Chr1:1p32.3-31.3 |
likely pathogenic |
NM_000098.3(CPT2):c.1646G>A (p.Gly549Asp) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453045]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453046]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003453044]|Carnitine palmitoyltransferase II deficiency [RCV000202475]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003453047]|not provided [RCV000591616] | Chr1:53213264 [GRCh38] Chr1:53678936 [GRCh37] Chr1:1p32.3 |
pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.983A>G (p.Asp328Gly) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000202505] | Chr1:53210657 [GRCh38] Chr1:53676329 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|not provided |
NM_000098.3(CPT2):c.1925_1937del (p.Lys642fs) | deletion | Carnitine palmitoyltransferase II deficiency [RCV000202522] | Chr1:53213540..53213552 [GRCh38] Chr1:53679212..53679224 [GRCh37] Chr1:1p32.3 |
pathogenic|not provided |
NM_000098.3(CPT2):c.1737del (p.Ala578_Tyr579insTer) | deletion | Carnitine palmitoyltransferase II deficiency [RCV000202525] | Chr1:53213355 [GRCh38] Chr1:53679027 [GRCh37] Chr1:1p32.3 |
pathogenic|not provided |
NM_000098.3(CPT2):c.1145G>A (p.Arg382Lys) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000202539] | Chr1:53210819 [GRCh38] Chr1:53676491 [GRCh37] Chr1:1p32.3 |
pathogenic|not provided |
NM_000098.3(CPT2):c.641T>C (p.Met214Thr) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000202541] | Chr1:53210315 [GRCh38] Chr1:53675987 [GRCh37] Chr1:1p32.3 |
pathogenic|not provided |
NM_000098.3(CPT2):c.452G>A (p.Arg151Gln) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000984253]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002477298]|Carnitine palmitoyltransferase II deficiency [RCV000202567]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474724]|not provided [RCV000492874] | Chr1:53210126 [GRCh38] Chr1:53675798 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.886C>T (p.Arg296Ter) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003989332]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169096]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002498726]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV004554716]|Carnitine palmitoyltransferase II deficiency [RCV000539401]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474808]|not provided [RCV000153105] | Chr1:53210560 [GRCh38] Chr1:53676232 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.953T>G (p.Val318Gly) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003453145]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003453146]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002483326]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003453144]|Carnitine palmitoyltransferase II deficiency [RCV001850089]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003453147]|not provided [RCV000153106] | Chr1:53210627 [GRCh38] Chr1:53676299 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1634A>C (p.Glu545Ala) | single nucleotide variant | CPT2-related disorder [RCV003952745]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000669380]|Carnitine palmitoyltransferase II deficiency [RCV001085202]|not provided [RCV000723709] | Chr1:53211308 [GRCh38] Chr1:53676980 [GRCh37] Chr1:1p32.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.1369A>T (p.Lys457Ter) | single nucleotide variant | CPT2-related disorder [RCV003947445]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169067]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000762944]|Carnitine palmitoyltransferase II deficiency [RCV000689502]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474897]|not provided [RCV001567590] | Chr1:53211043 [GRCh38] Chr1:53676715 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.1348A>T (p.Arg450Ter) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169371]|Carnitine palmitoyltransferase II deficiency [RCV001850399] | Chr1:53211022 [GRCh38] Chr1:53676694 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.38del (p.Gly13fs) | deletion | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000169434]|Carnitine palmitoyltransferase II deficiency [RCV002515200] | Chr1:53196978 [GRCh38] Chr1:53662650 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.587C>T (p.Pro196Leu) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454460]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454461]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454459]|Carnitine palmitoyltransferase II deficiency [RCV001345861]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456006]|not provided [RCV000178038] | Chr1:53210261 [GRCh38] Chr1:53675933 [GRCh37] Chr1:1p32.3 |
uncertain significance |
Single allele | indel | not provided [RCV000178039] | Chr1:53675880..53675904 [GRCh37] | uncertain significance |
NM_000098.3(CPT2):c.1342T>C (p.Phe448Leu) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001810398]|Carnitine palmitoyltransferase II deficiency [RCV000202478]|not provided [RCV000178040]|not specified [RCV000430397] | Chr1:53211016 [GRCh38] Chr1:53676688 [GRCh37] Chr1:1p32.3 |
pathogenic|benign|conflicting interpretations of pathogenicity|uncertain significance|other|not provided |
NM_000098.3(CPT2):c.674G>A (p.Arg225His) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV001563785]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV001563784]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001563783]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002478590]|Carnitine palmitoyltransferase II deficiency [RCV001852205]|not provided [RCV000178041] | Chr1:53210348 [GRCh38] Chr1:53676020 [GRCh37] Chr1:1p32.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.1460A>C (p.Glu487Ala) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV001056377]|not provided [RCV000178042] | Chr1:53211134 [GRCh38] Chr1:53676806 [GRCh37] Chr1:1p32.3 |
pathogenic|uncertain significance |
NM_000098.3(CPT2):c.1336G>A (p.Val446Ile) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000635372] | Chr1:53211010 [GRCh38] Chr1:53676682 [GRCh37] Chr1:1p32.3 |
likely benign|uncertain significance |
NM_000098.3(CPT2):c.1598T>C (p.Val533Ala) | single nucleotide variant | CPT2-related disorder [RCV003917702]|Carnitine palmitoyltransferase II deficiency [RCV001080230]|not provided [RCV000711322]|not specified [RCV000185827] | Chr1:53211272 [GRCh38] Chr1:53676944 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.1964C>A (p.Ser655Tyr) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV001322809]|Inborn genetic diseases [RCV004020250]|not specified [RCV000185828] | Chr1:53213582 [GRCh38] Chr1:53679254 [GRCh37] Chr1:1p32.3 |
likely benign|uncertain significance |
NM_000098.2(CPT2):c.1789G>C (p.Val597Leu) | single nucleotide variant | not specified [RCV000185835] | Chr1:53213407 [GRCh38] Chr1:53679079 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.353A>G (p.Asp118Gly) | single nucleotide variant | CPT2-related disorder [RCV003947559]|Carnitine palmitoyltransferase II deficiency [RCV001085585]|not provided [RCV000440638]|not specified [RCV001804920] | Chr1:53210027 [GRCh38] Chr1:53675699 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.852C>T (p.Pro284=) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000404930] | Chr1:53210526 [GRCh38] Chr1:53676198 [GRCh37] Chr1:1p32.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.1158A>C (p.Glu386Asp) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000405294] | Chr1:53210832 [GRCh38] Chr1:53676504 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.370C>T (p.Arg124Ter) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV000411770]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV000410924]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000409811]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001004158]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002500569]|Carnitine palmitoyltransferase II deficiency [RCV000707179]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474939]|not provided [RCV000185829] | Chr1:53210044 [GRCh38] Chr1:53675716 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.2(CPT2):c.631C>A (p.Pro211Thr) | single nucleotide variant | not provided [RCV000185830] | Chr1:53210305 [GRCh38] Chr1:53675977 [GRCh37] Chr1:1p32.3 |
likely pathogenic |
NM_000098.3(CPT2):c.691C>T (p.Arg231Trp) | single nucleotide variant | CPT2-related disorder [RCV003927721]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000674663]|Carnitine palmitoyltransferase II deficiency [RCV000796802]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474940]|not provided [RCV001092683]|not specified [RCV003230439] | Chr1:53210365 [GRCh38] Chr1:53676037 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.1048C>T (p.Arg350Cys) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454482]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454483]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454481]|Carnitine palmitoyltransferase II deficiency [RCV000635369]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003454484]|Inborn genetic diseases [RCV002516964]|not provided [RCV000656840] | Chr1:53210722 [GRCh38] Chr1:53676394 [GRCh37] Chr1:1p32.3 |
likely pathogenic|uncertain significance |
NM_000098.3(CPT2):c.1511C>T (p.Pro504Leu) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454485]|Carnitine palmitoyltransferase II deficiency [RCV000778986]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003474941]|not provided [RCV003144149] | Chr1:53211185 [GRCh38] Chr1:53676857 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.1763C>G (p.Ser588Cys) | single nucleotide variant | CPT2-related disorder [RCV003927722]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454487]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454488]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454486]|Carnitine palmitoyltransferase II deficiency [RCV000538455]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456007]|Inborn genetic diseases [RCV002516965]|not provided [RCV003736627]|not specified [RCV000594905] | Chr1:53213381 [GRCh38] Chr1:53679053 [GRCh37] Chr1:1p32.3 |
pathogenic|benign|likely benign |
NM_000098.3(CPT2):c.719C>T (p.Ala240Val) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV002609003] | Chr1:53210393 [GRCh38] Chr1:53676065 [GRCh37] Chr1:1p32.3 |
likely pathogenic|uncertain significance |
NM_000098.3(CPT2):c.1578T>C (p.Gly526=) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449028]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449029]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002487317]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003449027]|Carnitine palmitoyltransferase II deficiency [RCV000262532]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456066]|not provided [RCV001729515]|not specified [RCV000614451] | Chr1:53211252 [GRCh38] Chr1:53676924 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_000098.3(CPT2):c.588T>C (p.Pro196=) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449025]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449026]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003449024]|Carnitine palmitoyltransferase II deficiency [RCV000290783]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456065]|not specified [RCV000419277] | Chr1:53210262 [GRCh38] Chr1:53675934 [GRCh37] Chr1:1p32.3 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 1p36.12-12(chr1:20608823-120546301)x3 | copy number loss | not provided [RCV000762767] | Chr1:20608823..120546301 [GRCh37] Chr1:1p36.12-12 |
likely benign |
NM_000098.3(CPT2):c.1608dup (p.Lys537fs) | duplication | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000669311]|Carnitine palmitoyltransferase II deficiency [RCV001215229]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV004568523] | Chr1:53211280..53211281 [GRCh38] Chr1:53676952..53676953 [GRCh37] Chr1:1p32.3 |
pathogenic|likely pathogenic |
NM_000098.3(CPT2):c.401_404del (p.Phe134fs) | deletion | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000670602] | Chr1:53210073..53210076 [GRCh38] Chr1:53675745..53675748 [GRCh37] Chr1:1p32.3 |
likely pathogenic |
NM_000098.3(CPT2):c.1508G>A (p.Arg503His) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000357481] | Chr1:53211182 [GRCh38] Chr1:53676854 [GRCh37] Chr1:1p32.3 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.3(CPT2):c.1952T>G (p.Leu651Ter) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000670407] | Chr1:53213570 [GRCh38] Chr1:53679242 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1375C>T (p.Gln459Ter) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000670434] | Chr1:53211049 [GRCh38] Chr1:53676721 [GRCh37] Chr1:1p32.3 |
likely pathogenic |
NM_000098.3(CPT2):c.1383G>A (p.Leu461=) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV001503653] | Chr1:53211057 [GRCh38] Chr1:53676729 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.3(CPT2):c.1335C>T (p.Cys445=) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000311919] | Chr1:53211009 [GRCh38] Chr1:53676681 [GRCh37] Chr1:1p32.3 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_000098.2(CPT2):c.-242G>C | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000273378] | Chr1:53196702 [GRCh38] Chr1:53662374 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.757A>G (p.Ile253Val) | single nucleotide variant | not specified [RCV000516342] | Chr1:53210431 [GRCh38] Chr1:53676103 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.2(CPT2):c.-285C>A | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000277039] | Chr1:53196659 [GRCh38] Chr1:53662331 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.2(CPT2):c.-461T>C | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000362496] | Chr1:53196483 [GRCh38] Chr1:53662155 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.2(CPT2):c.-477C>T | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000307837] | Chr1:53196467 [GRCh38] Chr1:53662139 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.2(CPT2):c.-242G>A | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000368164]|not provided [RCV004710789] | Chr1:53196702 [GRCh38] Chr1:53662374 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.3(CPT2):c.577C>T (p.Arg193Cys) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000635374]|not provided [RCV001508866]|not specified [RCV000305853] | Chr1:53210251 [GRCh38] Chr1:53675923 [GRCh37] Chr1:1p32.3 |
likely benign|uncertain significance |
NM_000098.3(CPT2):c.-117G>T | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000260538] | Chr1:53196827 [GRCh38] Chr1:53662499 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.853G>A (p.Glu285Lys) | single nucleotide variant | CPT2-related disorder [RCV003967801]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454830]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454831]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002502152]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454829]|Carnitine palmitoyltransferase II deficiency [RCV000813356]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456048]|not provided [RCV000310684] | Chr1:53210527 [GRCh38] Chr1:53676199 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_017887.3(CZIB):c.*462_*464dup | duplication | Carnitine palmitoyltransferase II deficiency [RCV000268466] | Chr1:53214194..53214195 [GRCh38] Chr1:53679866..53679867 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1559C>T (p.Pro520Leu) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003454818]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003454819]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003454817]|Carnitine palmitoyltransferase II deficiency [RCV001096808]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456047]|not provided [RCV000333706] | Chr1:53211233 [GRCh38] Chr1:53676905 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1712C>G (p.Pro571Arg) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, neonatal form [RCV002283688] | Chr1:53213330 [GRCh38] Chr1:53679002 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.683A>G (p.Lys228Arg) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000345825] | Chr1:53210357 [GRCh38] Chr1:53676029 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.-101C>A | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000315815] | Chr1:53196843 [GRCh38] Chr1:53662515 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.1438G>A (p.Gly480Arg) | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003449474]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003449475]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000669097]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV000763960]|Carnitine palmitoyltransferase II deficiency [RCV000635370]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456084]|Inborn genetic diseases [RCV004023502]|not provided [RCV003488648]|not specified [RCV000517111] | Chr1:53211112 [GRCh38] Chr1:53676784 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.2(CPT2):c.-229G>T | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000319362] | Chr1:53196715 [GRCh38] Chr1:53662387 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.388A>C (p.Asn130His) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000284790] | Chr1:53210062 [GRCh38] Chr1:53675734 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_017887.3(CZIB):c.*453A>G | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000354722]|not provided [RCV004715129] | Chr1:53214206 [GRCh38] Chr1:53679878 [GRCh37] Chr1:1p32.3 |
benign |
NM_000098.3(CPT2):c.1839G>T (p.Gly613=) | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000551928] | Chr1:53213457 [GRCh38] Chr1:53679129 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.3(CPT2):c.236A>C (p.Lys79Thr) | single nucleotide variant | CPT2-related disorder [RCV003403273]|Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003451158]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003451159]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV001449651]|Carnitine palmitoyltransferase II deficiency [RCV000530003]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003456089]|Genu valgum [RCV000626610]|Inborn genetic diseases [RCV004023832]|not provided [RCV001571245] | Chr1:53202325 [GRCh38] Chr1:53667997 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.*439T>C | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000353884] | Chr1:53214034 [GRCh38] Chr1:53679706 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.2(CPT2):c.-216A>G | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000373970] | Chr1:53196728 [GRCh38] Chr1:53662400 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.2(CPT2):c.-282C>T | single nucleotide variant | Carnitine palmitoyl transferase II deficiency, myopathic form [RCV003445911]|Carnitine palmitoyl transferase II deficiency, neonatal form [RCV003445912]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV002487316]|Carnitine palmitoyl transferase II deficiency, severe infantile form [RCV003445910]|Carnitine palmitoyltransferase II deficiency [RCV000313432]|Encephalopathy, acute, infection-induced, susceptibility to, 4 [RCV003445913] | Chr1:53196662 [GRCh38] Chr1:53662334 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_000098.3(CPT2):c.152+3G>A | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000379295] | Chr1:53197098 [GRCh38] Chr1:53662770 [GRCh37] Chr1:1p32.3 |
uncertain significance |
NM_017887.3(CZIB):c.*457C>A | single nucleotide variant | Carnitine palmitoyltransferase II deficiency [RCV000299911] | Chr1:53214202 [GRCh38] Chr1:53679874 [GRCh37] Chr1:1p32.3 |
likely benign |
NM_000098.3( |